Florida / New York

Ph: 561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

Kromek’s Digital Detectors Used in World’s 1st Digital SPECT/CT Scanner for Higher Energy Imaging

Spectrum Dynamics Medical, has introduced the world’s first digital SPECT/CT scanner for higher energy imaging, using Kromek’s digital detectors.

Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, is pleased to announce that one of its key customers, Spectrum Dynamics Medical, has introduced the world’s first digital SPECT/CT scanner for higher energy imaging, using Kromek’s digital detectors.

Based on Spectrum Dynamics’ digital SPECT/CT platform, VERITON-CT 400 Series’ detector technology provides the benefits of increased sensitivity and throughput for Nuclear Medicine clinical applications using up to 400keV high-energy isotopes.

CZT is transforming the detector technology used in medical imaging leading to shorter scan times, lower radiation dose to the patient, and improved image quality and quantitative accuracy.

Kromek’s high-performance digital detectors, combined with Spectrum’s 360-degree, wide-bore SPECT/CT scanner and its advanced image reconstruction algorithms, increase the energy range up to 400 keV to support the throughput demand of current and new emerging nuclear medicine clinical applications.

The 400 Series digital detector technology sets new standards with a 2-4 times improvement in energy range, system sensitivity, and energy resolution. These improvements will significantly shorten the scan times associated with current analog or state-of-the-art digital technology.

Arnab Basu, CEO of Kromek Group, said: “We are delighted that our CZT detectors have been integrated into Spectrum Dynamics’ VERITON-CT 400 SPECT/CT systems. This enables enhanced image quality and breakthrough clinical capabilities in digital SPECT/CT. Spectrum Dynamics has long been at the forefront of developing next-generation SPECT/CT scanners to deliver better patient outcomes, and we are pleased to be part of this significant advance in nuclear medical imaging technology.”

Gilad Yoeli, CEO of Spectrum Dynamics, added: “Clinical users across the world provide us with feedback on the Nuclear Medicine challenges they face. Providing the technology to address such challenges is what drives us. The increased sensitivity, improved energy resolution, and broader energy range of Kromek’s detector technology make it the right choice for the 400 Series and the advanced imaging and quantitative accuracy clinical users ask for.”

More Posts

Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business

SpringWorks immediately adds revenue and accelerates mid- to long-term growth for Merck KGaA, Darmstadt, Germany’s Healthcare business sector. Acquisition marks the formation of a rare tumor business for Merck KGaA, Darmstadt, Germany including SpringWorks’ portfolio and pimicotinib. SpringWorks’ rare tumor portfolio includes Ogsiveo, a first-in-disease systemic therapy for adults with desmoid tumors and Gomekli a first and only approved therapy for adults and children with NF1-PN.